International GNE Myopathy Patient Registry (GNE001)
Data Collection
Collected from today forward - ProspectiveMuscular Diseases+6
+ Muscular Dystrophies
+ Musculoskeletal Diseases
Cohort
Tracking disease incidence in order to identify risk factors and understand disease progression over time.Summary
Study start date: March 1, 2014
Actual date on which the first participant was enrolled.GNE myopathy is an ultra- rare condition. Most of the knowledge is coming from case reports or small cohort observations. There is a need to more precisely understand the long-term disease course and the progression of disease-specific features of GNE myopathy, and in turn characterise the overall burden of this illness. Also, to better understand the disease, describe it variability, genotype-phenotype correlation, quality of life, epidemiology, health-economics aspects and need for assistive walking devices. Collected data needs to be harmonised to be compatible collaborative work with Remudy (Japanese patient registry). This collaborative effort will enable the analysis of the largest GNE myopathy data set in the world. To this end, this study will collect patient information longitudinally. Upon patient's agreement, the registry curator can contact nominated clinicians to request additional data or data validation. Study Objectives The objectives of the study are to: * Longitudinally characterize disease-specific features of GNE myopathy * Characterize the burden of illness and quality of life in patients with GNE myopathy * Support recruitment in research activities * Inform registry participants via newsletters about scientific developments in the GNE myopathy field
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.430 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Cohort
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
John Walton Muscular Dystrophy Research Centre
Newcastle upon Tyne, United KingdomOpen John Walton Muscular Dystrophy Research Centre in Google Maps